ACM
Atika Capital Management Portfolio holdings
AUM
$957M
This Quarter Return
+12.58%
1 Year Return
+61.67%
3 Year Return
+345.35%
5 Year Return
+907.8%
10 Year Return
+13,504.21%
AUM
$655M
AUM Growth
+$655M
(-26%)
Cap. Flow
-$263M
Cap. Flow
% of AUM
-40.1%
Top 10 Holdings %
Top 10 Hldgs %
45.36%
Holding
103
New
17
Increased
7
Reduced
32
Closed
21
Top Buys
| 1 |
DexCom
DXCM
|
$16M |
| 2 |
Mastercard
MA
|
$12.2M |
| 3 |
Corteva
CTVA
|
$10.2M |
| 4 |
Manchester United
MANU
|
$9.53M |
| 5 |
Tandem Diabetes Care
TNDM
|
$9.09M |
Top Sells
| 1 |
Palo Alto Networks
PANW
|
$24.1M |
| 2 |
Liberty Media Series C
FWONK
|
$20.8M |
| 3 |
Amazon
AMZN
|
$19.8M |
| 4 |
SGEN
Seagen Inc. Common Stock
SGEN
|
$14.9M |
| 5 |
CrowdStrike
CRWD
|
$14.8M |
Sector Composition
| 1 | Healthcare | 38.88% |
| 2 | Technology | 33.77% |
| 3 | Communication Services | 11.29% |
| 4 | Industrials | 5.61% |
| 5 | Materials | 3.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
BWX Technologies
BWXT
$14.8B
| $9.5M | 1.37% |
163,573
+39,203
| +32% | +$2.28M |
|
27
Coty
COTY
$3.73B
| $9.11M | 1.31% |
1,064,343
-636,862
| -37% | -$5.45M |
|
|
28
Tandem Diabetes Care
TNDM
$845M
| $9.09M | 1.31% |
+202,280
| New | +$9.09M |
|
29
Pool Corp
POOL
$11.6B
| $9.01M | 1.3% |
29,804
-42,196
| -59% | -$12.8M |
|
30
NVIDIA
NVDA
$4.24T
| $8.91M | 1.28% |
61,000
-9,000
| -13% | -$1.32M |
|
31
Atlanta Braves Holdings Series B
BATRK
$2.82B
| $8.32M | 1.2% |
258,061
-46,439
| -15% | -$1.5M |
|
32
Procept Biorobotics
PRCT
$2.23B
| $8.3M | 1.19% |
199,690
+78,765
| +65% | +$3.27M |
|
33
Ferguson
FERG
$46.4B
| $7.97M | 1.15% |
62,741
-34,259
| -35% | -$4.35M |
|
34
BILL Holdings
BILL
$4.72B
| $7.69M | 1.11% |
70,560
-59,440
| -46% | -$6.48M |
|
35
BioMarin Pharmaceuticals
BMRN
$11.2B
| $7.63M | 1.1% |
+73,739
| New | +$7.63M |
|
|
DEN
36
DELISTED
Denbury Inc.
DEN
| $7.44M | 1.07% |
85,500
-124,500
| -59% | -$10.8M |
|
37
Zai Lab
ZLAB
$3.68B
| $7.3M | 1.05% |
237,656
-112,344
| -32% | -$3.45M |
|
38
SentinelOne
S
$6.29B
| $6.88M | 0.99% |
+471,610
| New | +$6.88M |
|
39
Shoals Technologies Group
SHLS
$1.09B
| $6.78M | 0.98% |
+275,000
| New | +$6.78M |
|
|
ITCI
40
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $6.3M | 0.91% |
119,000
-44,900
| -27% | -$2.38M |
|
41
FIVE9
FIVN
$2.08B
| $5.82M | 0.84% |
+85,800
| New | +$5.82M |
|
42
Prothena Corp
PRTA
$441M
| $5.49M | 0.79% |
+91,178
| New | +$5.49M |
|
43
Jacobs Solutions
J
$17.5B
| $5.31M | 0.76% |
44,261
-35,739
| -45% | -$4.29M |
|
44
Enovix
ENVX
$1.89B
| $4.95M | 0.71% |
398,130
-601,870
| -60% | -$7.49M |
|
45
Roivant Sciences
ROIV
$8.15B
| $4.47M | 0.64% |
+560,000
| New | +$4.47M |
|
46
Avery Dennison
AVY
$13.4B
| $3.85M | 0.55% |
+21,245
| New | +$3.85M |
|
47
Biohaven
BHVN
$1.63B
| $3.31M | 0.48% |
+238,413
| New | +$3.31M |
|
48
Cytokinetics
CYTK
$4.23B
| $3.02M | 0.43% |
66,000
-94,310
| -59% | -$4.32M |
|
49
Tesla
TSLA
$1.08T
| $2.65M | 0.38% |
+21,500
| New | +$2.65M |
|
50
Novo Nordisk
NVO
$251B
| $2.52M | 0.36% |
+18,589
| New | +$2.52M |
|